By ALPS Funds Last week, the ALPS Medical Breakthroughs ETF (SBIO) posted gains of around 1% and outperformed broader equity markets as well as large-cap biotech indices. Valuations for SBIO’s small-to-mid cap biotech holdings were buoyed by positive M&A (merger & acquisition) sentiment...